An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study

INTRODUCTION: Xerosis is a common skin side effect of current anticancer therapies, including chemotherapy, targeted therapy, radiotherapy, and hormonotherapy. We evaluated the effectiveness of an emollient PLUS containing an Aquaphilus dolomiae extract (ADE-G1) for the management of xerosis in adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Vendrely, Véronique, Mayor-Ibarguren, Ander, Stennevin, Aline, Ortiz-Brugués, Ariadna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941027/
https://www.ncbi.nlm.nih.gov/pubmed/35107817
http://dx.doi.org/10.1007/s13555-022-00685-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941027/
https://www.ncbi.nlm.nih.gov/pubmed/35107817
http://dx.doi.org/10.1007/s13555-022-00685-2

Ejemplares similares